A Dose-Ranging Study of the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in COPD
Respiratory Research - United Kingdom
doi 10.1186/s12931-020-1307-4
Full Text
Open PDFAbstract
Available in full text
Date
February 10, 2020
Authors
Publisher
Springer Science and Business Media LLC